Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion type Assertion NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_head.
- NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion description "[EGFR intron 1 polymorphism may influence response to treatment with tyrosine kinase inhibitors in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_provenance.
- NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion evidence source_evidence_literature NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_provenance.
- NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion SIO_000772 17102595 NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_provenance.
- NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion wasDerivedFrom lhgdn-20090331 NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_provenance.
- NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_assertion wasGeneratedBy ECO_0000203 NP220839.RAUPJ81yXC_vnOyxhnBy16Fu2zAw0KAP1eJI6P7pGX208130_provenance.